1 |
烟雾病和烟雾综合征诊断与治疗中国专家共识编写组, 国家卫生计生委脑卒中防治专家委员会缺血性卒中外科专业委员会. 烟雾病和烟雾综合征诊断与治疗中国专家共识(2017) [J]. 中华神经外科杂志, 2017, 33(6): 541-547.
|
2 |
Satoshi K, Kiyohiro H, Tatsuya I, et al. Novel bypass surgery for moyamoya disease using pericranial flap: its impacts on cerebral hemodynamics and long-term outcome [J]. Neurosurgery, 2010, 66(6): 1093-1101; discussion 1101.
|
3 |
Narducci A, Yasuyuki K, Onken J, et al. In vivo demonstration of blood-brain barrier impairment in moyamoya disease [J]. Acta Neurochir (Wien), 2019, 161(2): 371-378.
|
4 |
Kamp MA, Slotty P, Turowski B, et al. Microscope-integrated quantitative analysis of intraoperative indocyanine green fluorescence angiography for blood flow assessment: first experience in 30 patients [J]. Neurosurgery, 2012, 70(1 Suppl Operative): 65-73; discussion 73-74.
|
5 |
Acerbi F, Broggi M, Eoli M, et al. Fluorescein-guided surgery for grade Ⅳ gliomas with a dedicated filter on the surgical microscope: preliminary results in 12 cases [J]. Acta Neurochir (Wien), 2013, 155(7): 1277-1286.
|
6 |
Schebesch KM, Proescholdt M, HöhneJulius, et al. Sodium fluorescein-guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery--a feasibility study [J]. Acta Neurochir (Wien), 2013, 155(4): 693-699.
|
7 |
Egashira Y, Yamauchi K, Enomoto Y, et al. Disruption of Cortical Arterial Network is Associated with the Severity of Transient Neurologic Events After Direct Bypass Surgery in Adult Moyamoya Disease [J]. World Neurosurg, 2017, 100: 311-315.
|
8 |
张白, 惠品晶, 惠国桢, 等. Moyamoya病血管吻合术前后脑血流动力学改变的研究 [J]. 中风与神经疾病杂志, 2013, 30(9): 785-787.
|
9 |
Hayashi T, Shirane R, Fujimura M, et al. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion [J]. J Neurosurg Pediatr, 2010, 6(1): 73-81.
|
10 |
Tu XK, Fujimura M, Rashad S, et al. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift' [J]. Neurosurg Rev, 2017, 40(3): 507-512.
|
11 |
廖煜君, 李京润, 徐斌. 烟雾病搭桥术后暂时性神经功能障碍的分析 [J]. 中国微侵袭神经外科杂志, 2017, 22(11): 492-495.
|
12 |
Rosenberg GA. Neurological diseases in relation to the blood-brain barrier [J]. J Cereb Blood Flow Metab, 2012, 32(7): 1139-1151.
|
13 |
Blecharz KG, Frey D, Schenkel T, et al. Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in moyamoya disease [J]. J Cereb Blood Flow Metab, 2017, 37(4): 1527-1539.
|
14 |
Fujimura M, Watanabe M, Narisawa A, et al. Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease [J]. Surg Neurol, 2009, 72(5): 476-480; discussion 480.
|
15 |
Uchino H, Nakayama N, Kazumata K, et al. Edaravone reduces hyperperfusion-related neurological deficits in adult moyamoya disease: historical control study [J]. Stroke, 2016, 47(7): 1930-1932.
|
16 |
Dumont AS, Tjoumakaris SI, Jabbour PM, et al. Cerebral hyperperfusion after neurovascular reconstruction surgery: what have we learned? [J]. World Neurosurg, 2012, 78(5): 415-417.
|
17 |
Uchino H, Kazumata K, Ito M, et al. Intraoperative assessment of cortical perfusion by indocyanine green videoangiography in surgical revascularization for moyamoya disease [J]. Acta Neurochir (Wien), 2014, 156(9): 1753-1760.
|
18 |
Kobayashi S, Ishikawa T, Tanabe J, et al. Quantitative cerebral perfusion assessment using microscope-integrated analysis of intraoperative indocyanine green fluorescence angiography versus positron emission tomography in superficial temporal artery to middle cerebral artery anastomosis [J]. Surg Neurol Int, 2014, 5: 135.
|